… Invasive aspergillosis is an increasingly frequent disease in immunocompromised patients.
From 1970 to 1976 there was a 160% increase in cases of invasive aspergillosis diagnosed …

… In our experience, 22% of subjects in a cohort of 195 patients with documented invasive
aspergillosis (probable or proven disease according to the EORTC/MSG definition) would not …

… armamentarium and diagnostic modalities, invasive aspergillosis (IA) remains an important
cause of morbidity and mortality in immunocompromised patients. There is an emergence of …

… invasive aspergillus sinusitis occurs in healthy or only mildly immunocompromised patients
[… Most patients with chronic invasive aspergillosis have no discernible immunocompromising …

… neutrophilic granulocytes prevent invasive growth. These … Invasive aspergillosis is
characterised by hyphal invasion of … prognosis is poor especially in immunocompromised patients …

… invasive aspergillosis. We have moved from what was an almost uniformly fatal disease in
immunosuppressed patients … , immunocompromised patients with invasive aspergillosis have …

… The main issues in the diagnosis of invasive aspergillosis are the following: a test needs to
… invasive aspergillosis, also called invasive pulmonary aspergillosis or systemic aspergillosis…

… Aspergillus infection in immunocompetent patients is rare, it remains a significant cause of
morbidity and mortality in immunocompromised patients. The … immunosuppressed patients. …

… of invasive pulmonary aspergillosis that occurs in immunocompromised patients with …
therapy when localized invasive pulmonary aspergillosis developed in these patients. Between …

… Invasive aspergillosis (IA) is a major cause of morbidity and mortality in severely
immunocompromised patients. … Autopsy revealed invasive aspergillosis that was confined to the …